Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02265796 · ClinicalTrials.gov registry record · Phase 2
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
A Phase 2 study, sponsored by North Florida Foundation for Research and Education.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02265796: Completed Phase 2 study, sponsored by North Florida Foundation for Research and Education.
NCT02265796 is a Phase 2 study that has completed, run by North Florida Foundation for Research and Education. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02265796, a Phase 2 study, has completed, sponsored by North Florida Foundation for Research and Education.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a prospective, double-blind, placebo-controlled, randomized, single-center (North Florida- South Georgia VA Medical Center) study. The study objective is to determine if ranolazine improves angina symptoms at 4 months compared with placebo among stable coronary artery disease patients who have demonstrable myocardial ischemia, but who do not undergo revascularization
Primary Outcome
The SAQ quantifies patients' physical limitations caused by angina, the frequency of and recent changes in their symptoms, their satisfaction with treatment, and the degree to which they perceive their disease to affect their quality of life.Each of the 5 dimensions are scored by assigning eachresponse an ordinal value, beginning with 1 for the response that implies the lowest level of functioning, and summing across items within each of the 5 scales. Scale scores then transformed to 0-100 range
Interventions
- DRUG Ranolazine
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
What the finished NCT02265796 record still lists
NCT02265796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 2 interventions - of which Ranolazine is the first listed.
NCT02265796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02265796 about?
NCT02265796 is a clinical study titled "Ranolazine Among Unrevascularized Chronic Stable Angina Patients". This is a prospective, double-blind, placebo-controlled, randomized, single-center (North Florida- South Georgia VA Medical Center) study. The study objective is to determine if ranolazine improves angina symptoms at 4 months compared with placebo among stable coronary artery disease patients who ha...
What is the current status of trial NCT02265796?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2014-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02265796?
The interventions under investigation include: Ranolazine (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT02265796?
This trial is sponsored by North Florida Foundation for Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02265796's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia